JPMorgan China Growth & Income (JCGI) has published its annual results for the year ended 30 September 2022. During the period, JCGI provided an NAV total return of -36.7%, underperforming the MSCI China Index, which declined 22.0%. The Company delivered a return to ordinary shareholders of -38.5%, reflecting a widening in the discount at which […]
abrdn New Dawn (ABD) has published its interim results for the six months ended 31 October 2022. During the period, ABD provided an NAV total return of -12.7%, which is modestly ahead of the equivalent return on its benchmark, the MSCI All Countries Asia Pacific ex Japan Index, of -13.7% (all in sterling terms). The […]
River and Mercantile UK Micro Cap (RMMC) has published its annual results for the year ended 30 September 2022. During the period, RMMC provided an NAV total return of -48.03%, while its benchmark posted a total return of -26.91%. The chairman, Andrew Chapman says “There can be no doubt that the last year has been […]
JPMorgan Japanese (JFJ) has published its annual results for the year ended 30 September 2022. JFJ underperformed during the first half of its financial year and this continued into the second half, although both relative and absolute performance recovered in the final months of the financial year. Overall, JFJ’s NAV total return for the period […]
In QuotedData’s morning briefing 14 December 2022: International Biotechnology Trust (IBT) has announced that there has been a material adjustment to the valuation of an investment from the unquoted portfolio managed by SV Health Managers LLP in which IBT is invested. As such, IBT’s NAV will therefore increase by £2.5m (US$3.1m) which corresponds to a […]
This week, we’ve had annual results Finsbury Growth and Income (FGT), which I thought presented an opportunity to have a look at how the trust is doing and reflect upon our previous observations of the manager’s style. For most readers, FGT needs little introduction. It is a household name in the investment trust space, having […]
Rockwood Strategic’s (RKW)’s) portfolio company Crestchic, which accounted for 28.7% of RKW’s NAV as at 30 September 2022, has announced that it has agreed terms with Aggreko for a recommended cash offer to be made by Aggreko for the entire issued and to be issued ordinary share capital of Crestchic. Under the terms of the […]
International Public Partnerships (INPP) has agreed binding terms to acquire five infrastructure investments in New Zealand for around NZD 200m from Morrison & Co managed Public Infrastructure Partners. The Acquisition marks INPP’s first investment in New Zealand and will provide further diversification of INPP’s investment portfolio as well as a platform which should generate further […]
ThomasLloyd Energy Impact Trust (TLEP/TLEI) has announced a number of senior appointments at its investment manager, ThomasLloyd Global Asset Management (Americas) LLC (a wholly-owned subsidiary of ThomasLloyd Group Ltd). As yet unnamed chief investment officer (CIO) TLEP’s manager has recently agreed the appointment of a CIO. We do not know who this person is yet, […]
In QuotedData’s Morning briefing 9 December 2022: Syncona’s (SYNC’s) portfolio company Autolus Therapeutics Plc has announced the pricing of its underwritten public offering, in the US, of 75m American Depositary Shares (ADSs). These represent 75m ordinary shares and were issued at a price of US$2.00 per ADS, for total gross proceeds of approximately US$150m (£122.5m). […]
